LSA
REGN icon

Leonteq Securities AG’s Regeneron Pharmaceuticals REGN Stock Holding History

Leonteq Securities AG’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.46M Buy
3,948
+2,736
+226% +$1.86M 0.08% 154
2026
Q1 		$936K Sell
1,212
-130
-10% -$99.5K 0.03% 305
2025
Q4 		$1.04M Sell
1,342
-4,209
-76% -$2.86M 0.03% 318
2025
Q3 		$3.12M Buy
5,551
+1,445
+35% +$817K 0.09% 151
2025
Q2 		$2.16M Buy
4,106
+301
+8% +$168K 0.08% 152
2025
Q1 		$2.37M Buy
3,805
+1,978
+108% +$1.36M 0.13% 142
2024
Q4 		$1.3M Buy
1,827
+1,058
+138% +$888K 0.09% 199
2024
Q3 		$808K Buy
769
+4
+0.5% +$4.45K 0.06% 244
2024
Q2 		$804K Sell
765
-2
-0.3% -$1.94K 0.06% 232
2024
Q1 		$738K Sell
767
-173
-18% -$165K 0.06% 262
2023
Q4 		$826K Sell
940
-5
-0.5% -$4.12K 0.05% 270
2023
Q3 		$778K Sell
945
-1,125
-54% -$884K 0.04% 292
2023
Q2 		$1.49M Buy
2,070
+525
+34% +$405K 0.08% 232
2023
Q1 		$1.27M Sell
1,545
-1,244
-45% -$938K 0.06% 249
2022
Q4 		$2.01M Buy
2,789
+1,268
+83% +$936K 0.07% 191
2022
Q3 		$1.05M Sell
1,521
-114
-7% -$71.8K 0.04% 271
2022
Q2 		$966K Buy
1,635
+262
+19% +$170K 0.04% 290
2022
Q1 		$959K Sell
1,373
-971
-41% -$614K 0.03% 306
2021
Q4 		$1.48M Sell
2,344
-292
-11% -$180K 0.05% 262
2021
Q3 		$1.6M Sell
2,636
-251
-9% -$156K 0.07% 227
2021
Q2 		$1.61M Sell
2,887
-7,183
-71% -$3.64M 0.1% 191
2021
Q1 		$4.76M Buy
10,070
+1,908
+23% +$929K 0.28% 83
2020
Q4 		$3.94M Buy
+8,162
New +$4.41M 0.21% 94

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Leonteq Securities AG's REGN Position: Q2 2026 in Review

Leonteq Securities AG increased its Regeneron Pharmaceuticals (REGN) stake by 226% in Q2 2026, buying an estimated $1.86M and bringing the position to 3,948 shares worth $2.46M. The position accounts for 0.08% of the portfolio, ranked #154.

Leonteq Securities AG first reported a position in REGN in Q4 2020 and has held it in 23 quarters since. The position peaked at $4.76M in Q1 2021. 1,327 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Leonteq Securities AG held 3,948 shares of Regeneron Pharmaceuticals worth $2.46M as of Q2 2026.
  • Leonteq Securities AG bought 2,736 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $1.86M.
  • Regeneron Pharmaceuticals made up 0.08% of Leonteq Securities AG's portfolio in Q2 2026, its #154 holding.
  • Leonteq Securities AG first reported a position in Regeneron Pharmaceuticals in Q4 2020 and has held it in 23 quarters since.
  • Leonteq Securities AG's Regeneron Pharmaceuticals position peaked at $4.76M in Q1 2021.
  • 1,327 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Leonteq Securities AG's 13F filing for Q2 2026, filed 27 Jul 2026.